Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPTIVE testosterone trial in coronary atheroma
ACTRN12620000100998Phase 3Not yet recruiting
- Sponsor
- The University of Western Australia
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Reandron with Placebo (2 arms). Primary endpoint: Change in non-calcified coronary plaque volume. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
TSX-011
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12620000100998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000100998.